Ann Arbor, MI, United States of America

Richard F Keep

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Michigan. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard F Keep. Retrieved from https://idiyas.com/inventor/richard-f-keep

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richard F Keep: Innovator in Therapeutic Methods

Introduction

Richard F Keep is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of therapeutic methods, particularly in the treatment of diseases such as Gaucher disease and Fabry disease. With a total of 2 patents, his work has garnered attention in the medical community.

Latest Patents

Richard F Keep's latest patents focus on glucosylceramide synthase inhibitors. These patents disclose glucosylceramide synthase inhibitors and compositions containing the same. The methods outlined in these patents detail the use of glucosylceramide synthase inhibitors in treating diseases and conditions where inhibition of glucosylceramide synthase provides a benefit, such as Gaucher disease and Fabry disease.

Career Highlights

Richard F Keep is affiliated with the University of Michigan, where he continues to advance his research and innovations. His work has been instrumental in developing therapeutic methods that address critical health issues.

Collaborations

Some of Richard F Keep's coworkers include Scott D Larsen and Akira Abe. Their collaborative efforts contribute to the ongoing research and development in the field of therapeutic methods.

Conclusion

Richard F Keep's innovative work in glucosylceramide synthase inhibitors highlights his commitment to improving treatment options for serious diseases. His contributions to the field are invaluable and continue to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…